APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Mononucleotide (NMN)

The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.

Selected research

Industry Research

Nicotinamide Mononucleotide (NMN) Industry Research Report 2026

26 December 2025121 pages

Choose your research edition.

Industry ResearchNicotinamide Mononucleotide (NMN) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.

The main global Nicotinamide Mononucleotide (NMN) players include GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm, etc. The top four Nicotinamide Mononucleotide (NMN) players account for approximately 83% of the total market. Asia-Pacific is the largest consumer market for Nicotinamide Mononucleotide (NMN), accounting for about 76%, followed by Europe and Americas. In terms of type, Content ≥98% is the largest segment, with a share over 99%. And in terms of application, the largest application is Health Care Products, followed by Cosmetics.

The downstream applications of nicotinamide mononucleotide include health care products and cosmetics. Health products are the largest application market. In 2019, health products accounted for 98% of the total downstream consumption of nicotinamide mononucleotide in global.

Read the full market overview

Report Scope

This report quantifies the global Nicotinamide Mononucleotide (NMN) market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Nicotinamide Mononucleotide (NMN).

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nicotinamide Mononucleotide (NMN) Market by Company

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Nicotinamide Mononucleotide (NMN) Segment by Type

Content below 98%

Content above 98%

Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Kg) & (2021-2026) Table 6. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers Table 7. Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application Table 13. Global Nicotinamide Mononucleotide (NMN) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. GeneHarbor Company Information Table 18. GeneHarbor Business Overview Table 19. GeneHarbor Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 20. GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio Table 21. GeneHarbor Recent Development Table 22. Herbalmax Company Information Table 23. Herbalmax Business Overview Table 24. Herbalmax Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 25. Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio Table 26. Herbalmax Recent Development Table 27. Genex Formulas Company Information Table 28. Genex Formulas Business Overview Table 29. Genex Formulas Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 30. Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 31. Genex Formulas Recent Development Table 32. Shinkowa Pharmaceutical Company Information Table 33. Shinkowa Pharmaceutical Business Overview Table 34. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 35. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product Portfolio Table 36. Shinkowa Pharmaceutical Recent Development Table 37. Maac10 Formulas Company Information Table 38. Maac10 Formulas Business Overview Table 39. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 40. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 41. Maac10 Formulas Recent Development Table 42. EffePharm Company Information Table 43. EffePharm Business Overview Table 44. EffePharm Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio Table 46. EffePharm Recent Development Table 47. Bontac Company Information Table 48. Bontac Business Overview Table 49. Bontac Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 50. Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio Table 51. Bontac Recent Development Table 52. CELFULL Company Information Table 53. CELFULL Business Overview Table 54. CELFULL Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 55. CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio Table 56. CELFULL Recent Development Table 57. Kingdomway Company Information Table 58. Kingdomway Business Overview Table 59. Kingdomway Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio Table 61. Kingdomway Recent Development Table 62. Global Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Table 63. Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026) & (Kg) Table 64. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2026) Table 65. Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2027-2032) & (Kg) Table 66. Global Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2027-2032) Table 67. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2021-2026) & (US$ Million) Table 69. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2021-2026) Table 70. Global Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2027-2032) & (US$ Million) Table 71. Global Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2021-2026) Table 72. Global Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2027-2032) Table 73. Global Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Table 74. Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2021-2026) & (Kg) Table 75. Global Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021-2026) Table 76. Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2027-2032) & (Kg) Table 77. Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2027-2032) Table 78. North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 79. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 80. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 81. Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 82. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 83. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 84. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 85. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 86. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 87. South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 88. South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 89. South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 90. Global Nicotinamide Mononucleotide (NMN) Production by Type (2021-2026) & (Kg) Table 91. Global Nicotinamide Mononucleotide (NMN) Production by Type (2027-2032) & (Kg) Table 92. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2026) Table 93. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2027-2032) Table 94. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021-2026) & (US$ Million) Table 95. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2027-2032) & (US$ Million) Table 96. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021-2026) Table 97. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2027-2032) Table 98. Global Nicotinamide Mononucleotide (NMN) Price by Type (2021-2026) & (US$/Kg) Table 99. Global Nicotinamide Mononucleotide (NMN) Price by Type (2027-2032) & (US$/Kg) Table 100. Global Nicotinamide Mononucleotide (NMN) Production by Application (2021-2026) & (Kg) Table 101. Global Nicotinamide Mononucleotide (NMN) Production by Application (2027-2032) & (Kg) Table 102. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2026) Table 103. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2027-2032) Table 104. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021-2026) & (US$ Million) Table 105. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2027-2032) & (US$ Million) Table 106. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021-2026) Table 107. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2027-2032) Table 108. Global Nicotinamide Mononucleotide (NMN) Price by Application (2021-2026) & (US$/Kg) Table 109. Global Nicotinamide Mononucleotide (NMN) Price by Application (2027-2032) & (US$/Kg) Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Nicotinamide Mononucleotide (NMN) Distributors List Table 113. Nicotinamide Mononucleotide (NMN) Customers List Table 114. Nicotinamide Mononucleotide (NMN) Industry Trends Table 115. Nicotinamide Mononucleotide (NMN) Industry Drivers Table 116. Nicotinamide Mononucleotide (NMN) Industry Restraints Table 117. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nicotinamide Mononucleotide (NMN) Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Content below 98% Product Image Figure 7. Content above 98% Product Image Figure 8. Health Care Products Product Image Figure 9. Cosmetics Product Image Figure 10. Others Product Image Figure 11. Global Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 13. Global Nicotinamide Mononucleotide (NMN) Production Capacity (2021-2032) & (Kg) Figure 14. Global Nicotinamide Mononucleotide (NMN) Production (2021-2032) & (Kg) Figure 15. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2021-2032) Figure 16. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Nicotinamide Mononucleotide (NMN) Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Figure 20. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 30. North America Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 31. United States Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 32. United States Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 33. Canada Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 34. Mexico Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 35. Europe Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 36. Europe Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 37. Germany Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 38. France Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 39. U.K. Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 40. Italy Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 41. Russia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 42. Spain Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 43. Netherlands Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 44. Switzerland Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 45. Sweden Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 46. Poland Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 47. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 48. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 49. China Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 50. Japan Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 51. South Korea Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 52. India Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 53. Australia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 54. Taiwan Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 55. Southeast Asia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 56. South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 57. South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 58. Brazil Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 59. Argentina Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 60. Chile Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 61. Turkey Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 62. GCC Countries Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 63. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2032) Figure 64. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021-2032) Figure 65. Global Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2021-2032) Figure 66. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2032) Figure 67. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021-2032) Figure 68. Global Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2021-2032) Figure 69. Nicotinamide Mononucleotide (NMN) Value Chain Figure 70. Nicotinamide Mononucleotide (NMN) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Content below 98%
  • Content above 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • Shinkowa Pharmaceutical
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Nicotinamide Mononucleotide (NMN) by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Content below 98%
  5. 2.2.3 Content above 98%
  6. 2.3 Nicotinamide Mononucleotide (NMN) by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Health Care Products
  9. 2.3.3 Cosmetics
  10. 2.3.4 Others
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Nicotinamide Mononucleotide (NMN) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2021-2026)
  2. 3.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
  7. 3.7 Global Nicotinamide Mononucleotide (NMN) Manufacturers Established Date
  8. 3.8 Global Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GeneHarbor
  2. 4.1.1 GeneHarbor Nicotinamide Mononucleotide (NMN) Company Information
  3. 4.1.2 GeneHarbor Nicotinamide Mononucleotide (NMN) Business Overview
  4. 4.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 GeneHarbor Product Portfolio
  6. 4.1.5 GeneHarbor Recent Developments
  7. 4.2 Herbalmax
  8. 4.2.1 Herbalmax Nicotinamide Mononucleotide (NMN) Company Information
  9. 4.2.2 Herbalmax Nicotinamide Mononucleotide (NMN) Business Overview
  10. 4.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Herbalmax Product Portfolio
  12. 4.2.5 Herbalmax Recent Developments
  13. 4.3 Genex Formulas
  14. 4.3.1 Genex Formulas Nicotinamide Mononucleotide (NMN) Company Information
  15. 4.3.2 Genex Formulas Nicotinamide Mononucleotide (NMN) Business Overview
  16. 4.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Genex Formulas Product Portfolio
  18. 4.3.5 Genex Formulas Recent Developments
  19. 4.4 Shinkowa Pharmaceutical
  20. 4.4.1 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Company Information
  21. 4.4.2 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Business Overview
  22. 4.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Shinkowa Pharmaceutical Product Portfolio
  24. 4.4.5 Shinkowa Pharmaceutical Recent Developments
  25. 4.5 Maac10 Formulas
  26. 4.5.1 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Company Information
  27. 4.5.2 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Business Overview
  28. 4.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Maac10 Formulas Product Portfolio
  30. 4.5.5 Maac10 Formulas Recent Developments
  31. 4.6 EffePharm
  32. 4.6.1 EffePharm Nicotinamide Mononucleotide (NMN) Company Information
  33. 4.6.2 EffePharm Nicotinamide Mononucleotide (NMN) Business Overview
  34. 4.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 EffePharm Product Portfolio
  36. 4.6.5 EffePharm Recent Developments
  37. 4.7 Bontac
  38. 4.7.1 Bontac Nicotinamide Mononucleotide (NMN) Company Information
  39. 4.7.2 Bontac Nicotinamide Mononucleotide (NMN) Business Overview
  40. 4.7.3 Bontac Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Bontac Product Portfolio
  42. 4.7.5 Bontac Recent Developments
  43. 4.8 CELFULL
  44. 4.8.1 CELFULL Nicotinamide Mononucleotide (NMN) Company Information
  45. 4.8.2 CELFULL Nicotinamide Mononucleotide (NMN) Business Overview
  46. 4.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 CELFULL Product Portfolio
  48. 4.8.5 CELFULL Recent Developments
  49. 4.9 Kingdomway
  50. 4.9.1 Kingdomway Nicotinamide Mononucleotide (NMN) Company Information
  51. 4.9.2 Kingdomway Nicotinamide Mononucleotide (NMN) Business Overview
  52. 4.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Kingdomway Product Portfolio
  54. 4.9.5 Kingdomway Recent Developments
5 Global Nicotinamide Mononucleotide (NMN) Production by Region
  1. 5.1 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021-2032
  3. 5.2.1 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021-2026
  4. 5.2.2 Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2027-2032)
  5. 5.3 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021-2032
  7. 5.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021-2026
  8. 5.4.2 Global Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Nicotinamide Mononucleotide (NMN) Production and Value, YOY Growth
  11. 5.6.1 North America Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
6 Global Nicotinamide Mononucleotide (NMN) Consumption by Region
  1. 6.1 Global Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2021-2032)
  3. 6.2.1 Global Nicotinamide Mononucleotide (NMN) Consumption by Region: 2021-2026
  4. 6.2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2021-2032)
  2. 7.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2021-2032) & (Kg)
  3. 7.1.2 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2032)
  4. 7.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021-2032)
  5. 7.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2021-2032)
  2. 8.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2021-2032) & (Kg)
  3. 8.1.2 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2032)
  4. 8.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021-2032)
  5. 8.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 9.1.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Nicotinamide Mononucleotide (NMN) Production Mode & Process
  5. 9.2 Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Nicotinamide Mononucleotide (NMN) Distributors
  8. 9.2.3 Nicotinamide Mononucleotide (NMN) Customers
10 Global Nicotinamide Mononucleotide (NMN) Analyzing Market Dynamics
  1. 10.1 Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 10.2 Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 10.3 Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 10.4 Nicotinamide Mononucleotide (NMN) Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst